Next, KEGG pathway analyses of mRNA targets of DE miRNAs were conducted, revealing that these genes were enriched in the bladder cancer (Cdh1, Cdkn1a, Dapk2, E2f1, Egfr, Erbb2, Fgfr3, Nras, Mapk1), endometrial cancer (Axin1, Cdh1, Cdkn1a, Egfr, Erbb2, Nras, Pik3cd, Pik3r1, Tcf7l1, Mapk1, Gsk3b), and ErbB signaling (Nrg2, Camk2g, Cdkn1a, Cdkn1b, Egfr, Eif4ebp1, Erbb2, Nras, Pik3cd, Pik3r1, Stat5b, Pak6, Shc2, Mapk1, Gsk3b) pathways (Figure 3B). The gene discussed is FGFR3; the disease is endometrial cancer.